Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03578419|
Recruitment Status : Recruiting
First Posted : July 6, 2018
Last Update Posted : April 22, 2019
|Condition or disease||Intervention/treatment||Phase|
|Blood Loss Anemia||Device: Small-Volume Blood Collection Tubes Device: Standard-Volume Blood Collection Tubes||Not Applicable|
Blood sampling can cause significant unnecessary blood loss particularly in the intensive care unit (ICU). Blood loss contributes to anemia which is highly prevalent in the ICU and is associated with major adverse cardiovascular outcomes and death. Red blood cell (RBC) transfusions to correct anemia also have significant health risks.
Using a stepped wedge cluster randomized trial design, the specific aim of the STRATUS study is to evaluate whether the routine use of small-volume blood collection tubes reduces RBC transfusion compared to standard-volume blood collection tubes in adult ICU patients.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||10000 participants|
|Intervention Model:||Crossover Assignment|
|Intervention Model Description:||A stepped wedge cluster randomized trial in which ICUs (clusters) switch from a strategy of blood collection using standard-draw tubes (control) to soft-draw tubes (intervention). In this design, the timing at which individual ICUs switch to the intervention is randomly assigned.|
|Masking:||None (Open Label)|
|Official Title:||Small-Volume Tubes to Reduce Anemia and Transfusion: A Pragmatic Stepped Wedge Cluster Randomized Trial|
|Actual Study Start Date :||January 1, 2019|
|Estimated Primary Completion Date :||January 1, 2021|
|Estimated Study Completion Date :||June 1, 2021|
Active Comparator: Control Period
Standard-Volume Blood Collection Tubes
Device: Standard-Volume Blood Collection Tubes
Standard-volume (4 - 6 mL Vacutainer tubes, Beckton Dickinson) ethylenediaminetetraacetic acid (EDTA), lithium-heparin, citrate, fluoride and silica tubes.
Experimental: Intervention Period
Small-Volume Blood Collection Tubes ("soft-draw")
Device: Small-Volume Blood Collection Tubes
Small-volume (2 - 3 mL "soft-draw" Vacutainer tubes, Beckton Dickinson) ethylenediaminetetraacetic acid (EDTA), lithium-heparin, citrate, fluoride and silica tubes.
- RBC Transfusions [ Time Frame: through study completion, an average of 1.5 years ]Average number of red blood cell (RBC) units transfused per patient during ICU admission among patients admitted to ICU for 48 hours or longer.
- Hemoglobin Concentration [ Time Frame: through study completion, an average of 1.5 years ]Change in hemoglobin concentration from ICU admission to ICU discharge adjusted for number of RBC transfusions received
- ICU and hospital length of stay [ Time Frame: through study completion, an average of 1.5 years ]Length of stay in the ICU and hospital
- ICU and hospital mortality [ Time Frame: through study completion, an average of 1.5 years ]Mortality rates in the ICU and hospital
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03578419
|Contact: STRATUS Coordinator||9055212100 ext firstname.lastname@example.org|
|Hamilton General Hospital||Recruiting|
|Hamilton, Ontario, Canada, L8L 2X2|
|Contact: Stratus Study Coordinator, MD 9055212100 email@example.com|
|Principal Investigator:||Deborah Siegal, MD MSc FRCPC||Population Health Research Institute; McMaster University|
|Study Chair:||Stuart Connolly, MD||Population Health Research Institute; McMaster University|